BRIEF-Crescita Therapeutics total revenue $1.1 mln versus $29,000 last year

* Crescita Therapeutics Inc - qtrly net loss from continuing

operations (excluding immunology group which was discontinued)

was $1.4 million versus $2.3 million

Read more